目前和新兴的免疫疗法用于全身AL氨基粉症
Valeria Moreno1, Ludovic Saba1, Sara Tama-Shekan2
1Department of Hematology-Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
Discovery medicine
|September 26, 2024
概括
系统性轻链氨基粉症 (AL) 涉及错误折叠的蛋白质造成的器官损伤. 目前的治疗方法针对的是血细胞,新的治疗方法,如单克隆抗体,有望消除粉样蛋白沉积物.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 系统性轻链 (AL) 氨基粉症是一种罕见的血细胞瘤,由于氨基粉体沉积,导致器官功能障碍.
- 心脏参与显著恶化了AL氨基粉症的预后.
- 有效的治疗需要准潜在的血细胞克隆和粉样蛋白沉积物.
研究的目的:
- 为系统性AL氨基粉症提供当前和新兴疗法的全面审查.
- 为突出最近在AL粉样性粉症的免疫治疗策略的进步.
- 讨论未来治疗这种复杂疾病的方向.
主要方法:
- 目前关于AL氨基粉症治疗策略的文献综述.
- 对已批准的治疗方法进行分析,包括四重组治疗 (cyclophosphamide, bortezomib,dexamethasone,daratumumab).
- 探索新的治疗方法,包括单克隆抗体 (CAEL 101,伯塔米马布) 和干细胞移植.
主要成果:
- 四重疗法 (DaraCyborD) 是标准的第一线诱导AL氨基粉症.
- 自主干细胞移植是患者无法达到完全血液反应的选择.
- 针对粉样蛋白沉积物的单克隆抗体正在进行高级心脏AL粉样蛋白症的第三阶段试验.
结论:
- 针对AL粉样性粉症的治疗策略侧重于消除克隆性血细胞并防止进一步的粉样性沉积.
- 新兴的免疫疗法,特别是单克隆抗体,有可能直接去除粉样蛋白和修复器官.
- 对新型治疗方法的持续研究对于改善AL氨基粉症的结果至关重要.
相关概念视频
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

